Takeda Enters Into Two-Year Contract with Canadian Blood Ser

Availability of GLASSIA® represents significant milestone for patients with emphysema due to severe hereditary deficiency of Alpha-1 antitrypsin TORONTO, Dec. 20, 2023 /CNW/ - Takeda Canada Inc. (Takeda) has

Related Keywords

Japan , Canada , Toronto , Ontario , Canadians , Canadian , Angela Diano , Ken Chapman , Canadian Blood Services , Health Canada , Takeda Pharmaceutical Company Limited , Takeda Canada Inc , University Health Network , University Of Toronto , Asthma Airway Centre , Takeda Canada , Related Products , Airway Centre , Executive Director , Proteinase Inhibitor , Rute Fernandes , General Manager , Rare Genetics , Plasma Derived Therapies ,